CAPTRUST Financial Advisors’s Acumen Pharmaceuticals ABOS Stock Holding History

CAPTRUST Financial Advisors’s Portfolio ABOS Stock Details ABOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$37.2K	Buy	+15,757	New	+$40.2K	﹤0.01%	2924
2022 Q3	–	Sell	-1,000	Closed	-$5K	–	2069
2022 Q2	$5K	Sell	1,000 -576	-37%	-$2.16K	﹤0.01%	4053
2022 Q1	$6K	Buy	+1,576	New	+$8.57K	﹤0.01%	4044
2021 Q4	–	Sell	-78	Closed	-$1K	–	4748
2021 Q3	$1K	Buy	+78	New	+$1.3K	﹤0.01%	4391

Other funds holding ABOS

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

SCV

Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

KIA

Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

CAPTRUST Financial Advisors's ABOS Position: Q1 2026 in Review

CAPTRUST Financial Advisors opened a new position in Acumen Pharmaceuticals (ABOS) in Q1 2026: 15,757 shares worth $37.2K. The stake represents ﹤0.01% of the portfolio and ranks #2924 among its holdings. This is a return to the name: CAPTRUST Financial Advisors previously reported a position in ABOS as recently as Q2 2022.

CAPTRUST Financial Advisors first reported a position in ABOS in Q3 2021 and has held it in 4 quarters since. 84 funds tracked by Wall St. Rank hold ABOS as of Q1 2026.

CAPTRUST Financial Advisors held 15,757 shares of Acumen Pharmaceuticals worth $37.2K as of Q1 2026.
Acumen Pharmaceuticals was a new CAPTRUST Financial Advisors position in Q1 2026.
Acumen Pharmaceuticals made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #2924 holding.
CAPTRUST Financial Advisors first reported a position in Acumen Pharmaceuticals in Q3 2021 and has held it in 4 quarters since.
84 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q1 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.